Filing Details
- Accession Number:
- 0001127602-12-024001
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-07 20:58:03
- Reporting Period:
- 2012-08-03
- Filing Date:
- 2012-08-07
- Accepted Time:
- 2012-08-07 20:58:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1190632 | J Stephen Ryan | 2525 Dupont Drive Irvine CA 92612 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-08-03 | 5,000 | $36.85 | 53,452 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-03 | 5,000 | $45.89 | 58,452 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-03 | 5,000 | $36.49 | 63,452 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-03 | 15,000 | $86.50 | 48,452 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-08-06 | 9,000 | $51.72 | 57,452 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-06 | 6,900 | $54.32 | 64,352 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-06 | 15,900 | $85.47 | 48,452 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-08-07 | 4,500 | $54.32 | 52,952 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-08-07 | 11,400 | $46.66 | 64,352 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-07 | 15,900 | $85.35 | 48,452 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Nonemployee Director Stock Option (Right to Buy) | Disposition | 2012-08-03 | 5,000 | $0.00 | 5,000 | $36.85 |
| Common Stock | Nonemployee Director Stock Option (Right to Buy) | Disposition | 2012-08-03 | 5,000 | $0.00 | 5,000 | $45.88 |
| Common Stock | Nonemployee Director Stock Option (Right to Buy) | Disposition | 2012-08-03 | 5,000 | $0.00 | 5,000 | $36.49 |
| Common Stock | Nonemployee Director Stock Option (Right to Buy) | Disposition | 2012-08-06 | 9,000 | $0.00 | 9,000 | $51.71 |
| Common Stock | Nonemployee Director Stock Option (Right to Buy) | Disposition | 2012-08-06 | 6,900 | $0.00 | 6,900 | $54.32 |
| Common Stock | Nonemployee Director Stock Option (Right to Buy) | Disposition | 2012-08-07 | 4,500 | $0.00 | 4,500 | $54.32 |
| Common Stock | Nonemployee Director Stock Option (Right to Buy) | Disposition | 2012-08-07 | 11,400 | $0.00 | 11,400 | $46.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2004-04-25 | 2013-04-24 | No | 4 | M | Direct |
| 0 | 2005-04-28 | 2014-04-28 | No | 4 | M | Direct |
| 0 | 2006-04-26 | 2015-04-26 | No | 4 | M | Direct |
| 0 | 2007-05-02 | 2016-05-02 | No | 4 | M | Direct |
| 4,500 | 2018-05-06 | No | 4 | M | Direct | |
| 0 | 2018-05-06 | No | 4 | M | Direct | |
| 0 | 2019-04-30 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $86.4375 to $86.5700, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.1500 to $85.6100, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $85.0700 to $85.6700, inclusive. The reporting person undertakes to provide Allergan, Inc., any securities holder of Allergan, Inc., or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
- Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant.
- Option is fully vested and exercisable upon the earlier to occur (i) the first anniversary of the grant date, or (ii) the annual meeting held during such calendar year at which one or more members of the board are standing for re-election following the date of grant.
Billionaire Hedge Funds
